Rasesh Shah

Rasesh has over 10 years of industry experience. Most recently, Rasesh served in progressive roles at Cipla, including helping to shape the branded US-focused neurology specialty portfolio as well as end-to-end management of clinical stage 505(b)(2) and NCE neurology programs. Prior to Cipla, Rasesh was a life sciences strategy consultant at SmartAnalyst, Inc. and has experience at Toxikon and other companies in the development and management of non-clinical studies. Rasesh received his MBA and Ph.D. in Toxicology from Texas Tech University.